Evaluation of quality of life, body image and surgical outcomes of robotic total laparoscopic hysterectomy and sentinel lymph node mapping in low-risk endometrial cancer patients - A Robotic Gyne Club study.
Aged
Body Image
/ psychology
Case-Control Studies
Endometrial Neoplasms
/ psychology
Female
Humans
Hysterectomy
/ psychology
Laparoscopy
/ psychology
Lymph Node Excision
/ methods
Middle Aged
Prospective Studies
Quality of Life
/ psychology
Robotic Surgical Procedures
/ psychology
Sentinel Lymph Node
Treatment Outcome
endometrial cancer
quality of life
robotic surgery
sentinel lymph node
single-site robotic surgery
Journal
Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
10
11
2019
revised:
08
03
2020
accepted:
10
03
2020
pubmed:
15
3
2020
medline:
25
11
2020
entrez:
15
3
2020
Statut:
ppublish
Résumé
The aims of the study were to evaluate quality of life, cosmetic results and surgical outcomes of robotic single-site and robotic multiport total laparoscopic hysterectomy with sentinel lymph node mapping in women treated for low-risk endometrial cancer. The study is a prospective, multicenter, case-control study conducted at Ospedale Santa Chiara in Trento and Novara and Pavia University Hospitals. Seventy-six consecutive patients with a biopsy-confirmed diagnosis of low-risk endometrial cancer or atypical endometrial hyperplasia who between January 2017 and January 2019 had undergone robotic total laparoscopic hysterectomy and sentinel lymph node mapping were included. Data on surgical outcomes, quality of life and cosmetic results were prospectively collected and analyzed based on the surgical approach with robotic single-site vs robotic multiport assistance. Patients' clinical characteristics, intra-operative parameters, sentinel lymph node mapping results and postoperative findings were prospectively recorded. Clinical follow up was performed 4 weeks and 6 and 12 months after surgery. Fifty-one patients underwent a robotic multiport procedure and 25 patients a robotic single-site surgery. There was one significant difference between the two groups in terms of patient characteristics: mean body mass index (BMI) in the multiport group was 29 kg/m For the treatment of low-risk endometrial cancer and atypical endometrial hyperplasia with total hysterectomy and sentinel lymph node mapping, the robotic single-port approach is comparable to the multiport procedure in terms of intraoperative and postoperative findings, and has an advantage in terms of shorter surgical times. Further studies are required to identify possible differences in quality of life and cosmetic results.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1238-1245Informations de copyright
© 2020 Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). Published by John Wiley & Sons Ltd.
Références
NCCN Guidelines. National Comprehensive Cancer Network guidelines for the treatment of uterine neoplasm. 2019. https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed February 11, 2019.
Colombo N, Creutzberg C, Amant F, et al., ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016;26:2-30.
Galaal K, Donkers H, Bryant A, Lopes AD. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. 2018;(10):CD006655.
Sinno AK, Fader AN. Robotic-assisted surgery in gynecologic oncology. Fertil Steril. 2014;102:922-932.
Paley PJ, Veljovich DS, Shah CA, et al. Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases. Am J Obstet Gynecol. 2011;204:551.e1-551.e9.
Jørgensen SL, Mogensen O, Wu C, et al. Nationwide introduction of minimally invasive robotic surgery for early-stage endometrial cancer and its association with severe complications. JAMA Surg. 2019;154:530-538.
Cela V, Freschi L, Simi G, Ruggiero M, Tana R, Pluchino N. Robotic single-site hysterectomy: feasibility, learning curve and surgical outcome. Surg Endosc. 2013;27:2638-2643.
Bogliolo S, Ferrero S, Cassani C, et al. Single-site versus multiport robotic hysterectomy in benign gynecologic diseases: a retrospective evaluation of surgical outcomes and cost analysis. J Minim Invasive Gynecol. 2016;23:603-609.
Tateo S, Nozza A, Del Pezzo C, Mereu L. Robotic single-site pelvic lymphadenectomy. Gynecol Oncol. 2014;134:631.
Yoon A, Yoo H-N, Lee Y-Y, et al. Robotic single-port hysterectomy, adnexectomy, and lymphadenectomy in endometrial cancer. J Minim Invasive Gynecol. 2015;22:322.
Sinno AK, Fader AN, Tanner EJ 3rd. Single-site robotic sentinel lymph node biopsy and hysterectomy in endometrial cancer. Gynecol Oncol. 2015;137:190.
Bogliolo S, Musacchi V, Cassani C, Babilonti L, Gardella B, Spinillo A. Robotic single-site technique allows pelvic lymphadenectomy in surgical staging of endometrial cancer. J Minim Invasive Gynecol. 2015;22:695-696.
Corrado G, Mereu L, Bogliolo S. Robotic single-site staging in endometrial cancer: a multi-institution study. Eur J Surg Oncol. 2016;42:1506-1511.
Mereu L, Pellegrini A, Carlin R, Terreno E, Prasciolu C, Tateo S. Feasibility of sentinel lymph node fluorescence detection during robotic laparoendoscopic single-site surgery in early endometrial cancer: a prospective case series. Gynecol Surg. 2018;15:14.
Moukarzel LA, Sinno AK, Fader AN, Tanner EJ. Comparing single-site and multiport robotic hysterectomy with sentinel lymph node mapping for endometrial cancer: surgical outcomes and costs analysis. J Minim Invasive Gynecol. 2017;24:977-983.
Vizza E, Chiofalo B, Cutillo G, et al. Robotic single-site radical hysterectomy plus pelvic lymphadenectomy in gynecological cancers. J Gynecol Oncol. 2018;29:e2.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-196.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
Dunker MS, Bemelman WA, Slors JF, Van DP, Gouma DJ. Functional outcome, quality of life, body image, and cosmetic results in patients after laparoscopic-assisted and conventional restorative proctocolectomy: a comparative study. Dis Colon Rectum. 2001;44:1800-1807.
Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Cancr Netw. 2014;12:288-297.
Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009;113:163-169.
Angioni S, Loddo A, Milano F, Piras B, Minerba L, Melis GB. Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysteroscopy and blind biopsy. J Minim Invasive Gynecol. 2008;15:87-91.
Papadia A, Gasparri ML, Buda A, Mueller MD. Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue. J Cancer Res Clin Oncol. 2017;143:2039-2048.
Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer. 1987;60:2035-2041.
Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer. 2006;106:812-819.
Leitao MM Jr, Kehoe S, Barakat RR, et al. Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology. Am J Obstet Gynecol. 2010;202:278.e1-278.e6.
Moukarzel LA, Fader AN, Tanner EJ. Feasibility of robotic-assisted laparoendoscopic single-site surgery in the gynecologic oncology setting. J Minim Invasive Gynecol. 2017;24:258-263.
Corrado G, Calagna G, Cutillo G, et al. The patient and observer scar assessment scale to evaluate the cosmetic outcomes of the robotic single-site hysterectomy in endometrial cancer. Int J Gynecol Cancer. 2018;28:194-199.
Bogliolo S, Cassani C, Musacchi V, Babilonti L, Gardella B, Spinillo A. Robotic single-site surgery in management of obese patients with early-stage endometrial cancer. J Minim Invasive Gynecol. 2015;22:697-699.
Corrado G, Chiantera V, Fanfani F, et al. Robotic hysterectomy in severely obese patients with endometrial cancer: a multicenter study. J Minim Invasive Gynecol. 2016;23:94-100.